Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 418-425

  Ameri, Pietro ^a   Canepa, Marco ^a,b   Fabbi, Patrizia ^a   Leoncini, Giovanna ^a   Milaneschi, Yuri ^b,c   Mussap, Michele ^d   AlGhatrif, Majd ^b   Balbi, Manrico ^a   Viazzi, Francesca ^a   Murialdo, Giovanni ^a   Pontremoli, Roberto ^a   Brunelli, Claudio ^a   Ferrucci, Luigi ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Aging; Atherosclerosis; Endothelial; IGF 1; Intima media thickness; Vitamin D

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; SOMATOMEDIN C; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ALDOSTERONE; GLYCOSYLATED HEMOGLOBIN; LIPID;

AGE DISTRIBUTION; AGED; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOTHESIS; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OXIDATIVE STRESS; SEASON; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; AGING; ALBUMINURIA; ANALOGS AND DERIVATIVES; BLOOD; DIET RESTRICTION; FOLLOW UP; HYPERTENSION; ITALY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; UMBILICAL VEIN ENDOTHELIAL CELL; UNITED STATES; VASCULAR ENDOTHELIUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALBUMINURIA; ALDOSTERONE; APOPTOSIS; BALTIMORE; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; ITALY; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; VITAMIN D;

EID: 84907068484     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.08.022     Document Type: Article

References (55)

1. Delafontaine P., Song Y.H., Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24:435-444.
2. Higashi Y., Sukhanov S., Anwar A., Shai S.Y., Delafontaine P. Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci 2012, 67:626-639.
3. Ungvari Z., Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci 2012, 67:599-610.
4. Bailey-Downs L.C., Mitschelen M., Sosnowska D., Toth P., Pinto J.T., Ballabh P., et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci 2012, 67:313-329.
5. Thum T., Hoeber S., Froese S., Klink I., Stichtenoth D.O., Galuppo P., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100:434-443.
6. Shai S.Y., Sukhanov S., Higashi Y., Vaughn C., Rosen C.J., Delafontaine P. Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice. Am J Physiol Heart Circ Physiol 2011, 300:H1898-H1906.
7. Sukhanov S., Higashi Y., Shai S.Y., Vaughn C., Mohler J., Li Y., et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:2684-2690.
8. Johnsen S.H., Mathiesen E.B. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009, 11:21-27.
9. Janssen J.A., Stolk R.P., Pols H.A., Grobbee D.E., Lamberts S.W. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998, 18:277-282.
10. van den Beld A.W., Bots M.L., Janssen J.A., Pols H.A., Lamberts S.W., Grobbee D.E. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003, 157:25-31.
11. Boquist S., Ruotolo G., Skoglund-Andersson C., Tang R., Bjo¨rkegren J., Bond M.G., et al. Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men. Clin Endocrinol (Oxf) 2008, 68:51-58.
12. Kawachi S., Takeda N., Sasaki A., Kokubo Y., Takami K., Sarui H., et al. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:617-621.
13. Spilcke-Liss E., Friedrich N., Do¨rr M., Schminke U., Vo¨lzke H., Brabant G., et al. Serum insulin-like growth factor-I and its binding protein 3 in their relation to intima media thickness: results of the study of health in Pomerania (SHIP). Clin Endocrinol (Oxf) 2011 Feb 9, [Epub ahead of print]. 10.1111/j.1365-2265.2011.04010.x.
14. Hietaniemi M., Po¨ykko¨ S.M., Ukkola O., Pa¨iva¨nsalo M., Antero Kesa¨niemi Y. IGF-I concentrations are positively associated with carotid artery atherosclerosis in women. Ann Med 2005, 37:373-382.
15. Ameri P., Giusti A., Boschetti M., Murialdo G., Minuto F., Ferone D. Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin Endocrinol (Oxf) 2013, 79:457-463.
16. A1 Csiszar, Labinskyy N., Smith K., Rivera A., Orosz Z., Ungvari Z. Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol 2007, 170:388-398.
17. van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000, 192:1731-1744.
18. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
19. Shock N.W., Greulich R.C., Costa P.T., Andres R., Lakatta E.G., Arenberg D., et al. Normal human aging: the Baltimore longitudinal study of aging 1984, 45. NIH publication no. 84-2450, U.S. Government Printing Office, Washington, DC.
20. Pontremoli R., Sofia A., Ravera M., Nicolella C., Viazzi F., Tirotta A., et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Microalbuminuria: a Genoa investigation on complications. Hypertension 1997, 30:1135-1143.
21. Frystyk J., Freda P., Clemmons D.R. The current status of IGF-I assays - a 2009 update. Growth Horm IGF Res 2010, 20:8-18.
22. Koivula M.K., Turpeinen U., Laitinen P., Risteli J. Comparison of automated 25-OH vitamin D immunoassays with liquid chromatography isotope dilution tandem mass spectrometry. Clin Lab 2012, 58:1253-1261.
23. Nagai Y., Metter E.J., Earley C.J., Kemper M.K., Becker L.C., Lakatta E.G., et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998, 98:1504-1509.
24. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 1983, 80:3734-3737.
25. Uberti F., Lattuada D., Morsanuto V., Nava U., Bolis G., Vacca G., et al. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab 2014, 99:1367-1374.
26. 2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013, 6:221-231.
27. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
28. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930. Endocrine Society.
29. Wood A.D., Secombes K.R., Thies F., Aucott L., Black A.J., Mavroeidi A., et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012, 97:3557-3568.
30. Richart T., Thijs L., Nawrot T., Yu J., Kuznetsova T., Balkestein E.J., et al. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. Am J Hypertens 2011, 24:102-109.
31. Ameri P., Giusti A., Boschetti M., Bovio M., Teti C., Leoncini G., et al. Vitamin D increases circulating IGF1 in adults: potential implication for treatment of growth hormone deficiency. Eur J Endocrinol 2013, 169:767-772.
32. Oudshoorn C., van der Cammen T.J., McMurdo M.E., van Leeuwen J.P., Colin E.M. Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation. Br J Nutr 2009, 101:1597-1606.
33. Vimaleswaran K.S., Berry D.J., Lu C., Tikkanen E., Pilz S., Hiraki L.T., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10:e1001383.
34. Wen Z.Z., Cai M.Y., Mai Z., Jin D.M., Chen Y.X., Huang H., et al. Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction. PLoS One 2013, 8:e67242.
35. Davis L.K., Rodgers B.D., Kelley K.M. Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line. Endocrine 2008, 33:32-39.
36. Kassi E., Adamopoulos C., Basdra E.K., Papavassiliou A.G. Role of vitamin D in atherosclerosis. Circulation 2013, 128:2517-2531.
37. Merke J., Milde P., Lewicka S., Hu¨gel U., Klaus G., Mangelsdorf D.J., et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989, 83:1903-1915.
38. Wu-Wong J.R., Nakane M., Ma J., Ruan X., Kroeger P.E. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006, 186:20-28.
39. Tanaka H., Dinenno F.A., Monahan K.D., DeSouza C.A., Seals D.R. Carotid artery wall hypertrophy with age is related to local systolic blood pressure in healthy men. Arterioscler Thromb Vasc Biol 2001, 21:82-87.
40. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
41. Gao S., Wassler M., Zhang L., Li Y., Wang J., Zhang Y., et al. MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. Atherosclerosis 2014, 232:171-179.
42. Li Y., Shelat H., Wu H., Zhu M., Xu J., Geng Y.J. Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia. Int J Cardiol 2014, 171:272-273.
43. Murr C., Pilz S., Grammer T.B., Kleber M.E., Meinitzer A., Boehm B.O., et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen risk and cardiovascular health (LURIC) study. Clin Chem Lab Med 2012, 50:2205-2212.
44. Wolf M., Bo¨hm S., Brand M., Kreymann G. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 1996, 135:729-737.
45. Anwar A., Zahid A.A., Scheidegger K.J., Brink M., Delafontaine P. Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002, 105:1220-1225.
46. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
47. Jia G., Aggarwal A., Yohannes A., Gangahar D.M., Agrawal D.K. Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells. J Cell Mol Med 2011, 15:1695-1702.
48. Hannemann A., Wallaschofski H., Rettig R., Vo¨lzke H., Samietz S., Nauck M., et al. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population. Horm Metab Res 2012, 44:228-233.
49. Ameri P., Canepa M., Milaneschi Y., Spallarossa P., Leoncini G., Giallauria F., et al. Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore longitudinal study of aging. J Intern Med 2013, 273:253-262.
50. Lomashvili K.A., Wang X., O'Neill W.C. Role of local versus systemic vitamin D receptors in vascular calcification. Arterioscler Thromb Vasc Biol 2014, 34:146-151.
51. Deleskog A., Piksasova O., Silveira A., Gertow K., Baldassarre D., Veglia F., et al. Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2013, 33:2633-2638.
52. Blondon M., Sachs M., Hoofnagle A.N., Ix J.H., Michos E.D., Korcarz C., et al. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2013, 33:2639-2645.
53. Strawbridge R.J., Deleskog A., McLeod O., Folkersen L., Kavousi M., Gertow K., et al. A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia 2014, 57:1159-1172.
54. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.
55. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004, 14:337-375.